Page last updated: 2024-08-21

ethambutol and Alcohol Drinking

ethambutol has been researched along with Alcohol Drinking in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS	1
Becerra, MC; Calderon, RI; Contreras, CC; Galea, JT; Huang, CC; Lecca, LW; Mitnick, CD; Murray, MB; Velásquez, GE; Yataco, RM; Zhang, Z	1
Sbarbaro, JA	1

Reviews

1 review(s) available for ethambutol and Alcohol Drinking

Article	Year
Tuberculosis. The Medical clinics of North America, 1980, Volume: 64, Issue:3 Topics: Alcohol Drinking; Carrier State; Chemical and Drug Induced Liver Injury; Ethambutol; Humans; Isoniazid; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis, Pulmonary	1980

Other Studies

2 other study(ies) available for ethambutol and Alcohol Drinking

Article	Year
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. Respiratory medicine, 2017, Volume: 131 Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Amidohydrolases; Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Risk Factors; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Sputum; Tuberculosis, Multidrug-Resistant	2016

Article

Year

Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.

Respiratory medicine, 2017, Volume: 131

Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017

Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Amidohydrolases; Antitubercular Agents; Biological Assay; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Gene Expression; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Risk Factors; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Sputum; Tuberculosis, Multidrug-Resistant

2016